ARVO Meeting Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


This Article
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prusky, G.T.
Right arrow Articles by Lund, R.D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Prusky, G.T.
Right arrow Articles by Lund, R.D.
Invest Ophthalmol Vis Sci 2003;44: E-Abstract 512.
© 2003 ARVO


512—B487

Retinal Pigment Epthelial Cell Transplantation Limits the Loss of Vision Resulting From Retinal Degeneration

G.T. Prusky1, T.J. McGill1, B. Lu2, R.M. Douglas3 and R.D. Lund3

1 Psychology/Neuroscience, University Lethbridge, Lethbridge, AB, Canada
2 Moran Eye Center, University of Utah, Salt Lake City, UT, United States
3 Ophthalmology, University of British Columbia, Vancouver, BC, Canada

Commercial Relationships: G.T. Prusky, CerebralMechanics P; T.J. McGill, None; B. Lu, None; R.M. Douglas, CerebralMechanics P; R.D. Lund, None.

Grant Identification: Support: NSERC; Foundation Fighting Blindness; NIH-EY14038

Abstract

Dystrophic RCS rats undergo progressive photoreceptor degeneration over the first months of life, providing a model of human retinal degenerative disease. Transplantation of a human retinal pigment epithelial cell line, ARPE19, into the sub-retinal space of these rats early in life limits subsequent retinal degeneration. Purpose: In this study, we investigated whether limiting retinal degeneration with ARPE19 transplantation is an effective long-term method of preserving visual function. Method: We first characterized the spatial vision of non-dystrophic RCS rats, using the Visual Water Task, to determine whether the RCS strain itself has normal visual function. Next, we measured the visual acuity of dystrophic RCS rats, over time, to quantify the effect retinal deterioration has on cortical vision. Finally, we measured the visual acuity of monocularly and binocularly transplanted dystrophic RCS rats at various times after the surgery. Results: We found that non-dystrophic RCS rats had a grating acuity and contrast sensitivity that was normal for a pigmented rat. We also found that the acuity of dystrophic RCS rats declined from ~0.8 cycles/degree (cpd) at one month postnatal, to ~0.3 cpd by four months postnatal. There was a much slower decline in acuity thereafter. In addition, we found that both monocular and binocular transplants resulted in significantly improved vision over sham-operated controls, up to seven months of age. Conclusions: The results indicate that the RCS rat strain has no inherent spatial vision deficits, that dystrophic RCS rats lose cortical vision as their retinas degenerate, and that retinal transplantation of ARPE19 cells limits the progressive loss of visual function in dystrophic RCS rats for a significant period of time. Consequently, RPE cell transplantation may have therapeutic benefit for human retinal degenerative disease.

Keywords: transplantation • retinal pigment epithelium • age-related macular degeneration

 © 2003, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. For permission to reproduce any part of this abstract, contact the ARVO Office at arvo{at}arvo.org.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH